CN107488171B - 一种阿法替尼制备方法 - Google Patents
一种阿法替尼制备方法 Download PDFInfo
- Publication number
- CN107488171B CN107488171B CN201610406764.XA CN201610406764A CN107488171B CN 107488171 B CN107488171 B CN 107488171B CN 201610406764 A CN201610406764 A CN 201610406764A CN 107488171 B CN107488171 B CN 107488171B
- Authority
- CN
- China
- Prior art keywords
- reaction
- tert
- stirring
- afatinib
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610406764.XA CN107488171B (zh) | 2016-06-10 | 2016-06-10 | 一种阿法替尼制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610406764.XA CN107488171B (zh) | 2016-06-10 | 2016-06-10 | 一种阿法替尼制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107488171A CN107488171A (zh) | 2017-12-19 |
CN107488171B true CN107488171B (zh) | 2020-08-28 |
Family
ID=60641852
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610406764.XA Active CN107488171B (zh) | 2016-06-10 | 2016-06-10 | 一种阿法替尼制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107488171B (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0635498A1 (en) * | 1993-07-19 | 1995-01-25 | Zeneca Limited | Quinazoline derivatives and their use as anti-cancer agents |
CN104151359A (zh) * | 2014-07-15 | 2014-11-19 | 杭州华东医药集团新药研究院有限公司 | 喹唑啉类化合物及其制备方法和在制备酪氨酸激酶抑制剂中的应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10349113A1 (de) * | 2003-10-17 | 2005-05-12 | Boehringer Ingelheim Pharma | Verfahren zur Herstellung von Aminocrotonylverbindungen |
JP5241513B2 (ja) * | 2006-01-26 | 2013-07-17 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | アミノクロトニルアミノ置換キナゾリン誘導体の合成方法 |
CN103242303B (zh) * | 2013-05-16 | 2015-03-25 | 苏州明锐医药科技有限公司 | 阿法替尼的制备方法 |
CN104710413B (zh) * | 2013-12-16 | 2019-05-03 | 江苏豪森药业集团有限公司 | 二马来酸阿法替尼的制备方法 |
CN104926798B (zh) * | 2014-03-21 | 2019-06-18 | 江苏豪森药业集团有限公司 | 阿法替尼中间体的高纯度制备方法 |
-
2016
- 2016-06-10 CN CN201610406764.XA patent/CN107488171B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0635498A1 (en) * | 1993-07-19 | 1995-01-25 | Zeneca Limited | Quinazoline derivatives and their use as anti-cancer agents |
CN104151359A (zh) * | 2014-07-15 | 2014-11-19 | 杭州华东医药集团新药研究院有限公司 | 喹唑啉类化合物及其制备方法和在制备酪氨酸激酶抑制剂中的应用 |
Non-Patent Citations (2)
Title |
---|
Disclosed Anonymously.Process for the preparation of afatinib.《IP.com Journal》.2015,第15卷(第10A期),第1-3页. * |
Process for the preparation of afatinib;Disclosed Anonymously;《IP.com Journal》;20150930;第15卷(第10A期);第1-3页 * |
Also Published As
Publication number | Publication date |
---|---|
CN107488171A (zh) | 2017-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH04182442A (ja) | ネオペンチルグリコールの製造方法 | |
CN107488171B (zh) | 一种阿法替尼制备方法 | |
CN107488153B (zh) | 一种阿法替尼中间体化合物 | |
CN107488152B (zh) | 一种阿法替尼中间体及其合成方法 | |
CN107488194B (zh) | 一种阿法替尼中间体及其制备方法 | |
CN107056681B (zh) | 一种托法替布中间体的制备方法 | |
CN109810066A (zh) | 一种盐酸氨溴索有关物质的合成方法 | |
CN114195712B (zh) | 一种能够用来制备盐酸丙卡特罗的中间体及其制备方法 | |
CN107488172B (zh) | 一种阿法替尼的制备方法 | |
CN111116430B (zh) | 一种牛磺酸钠的制备方法 | |
CN111100042B (zh) | 一种2-甲氧基-5-磺酰胺基苯甲酸的制备方法 | |
CN112920233A (zh) | 一种改善其可加工性的甲维盐的合成方法 | |
US10611721B2 (en) | Method for preparing levobunolol hydrochloride | |
CN116947691B (zh) | 一种马来酸氟伏沙明的制备方法 | |
CN111978188B (zh) | 一种盐酸美西律杂质c的制备方法 | |
CN113372314B (zh) | 一种高纯度呋喃二烯晶体及其制备方法 | |
CN108084049B (zh) | 一种泊沙康唑中间体的制备方法 | |
CN110204490A (zh) | 一种二取代4-氯喹啉-3-甲腈衍生物及伯舒替尼的制备方法 | |
CN116589409A (zh) | 一种氯唑啉胺的化学合成方法 | |
CN115368317A (zh) | 一种用于制备阿立哌唑中间体的改善方法 | |
CN116283706A (zh) | 一种奈玛特韦中间体的制备方法 | |
CN116947746A (zh) | 一种匹可硫酸钠的制备方法 | |
CN113896642A (zh) | 一种2-((3,4-双(苄氧基)苄基)氨基)乙醇的合成方法 | |
CN113956239A (zh) | 一种盐酸氮卓斯汀及其制备方法和应用 | |
AU2020320499A1 (en) | Process for preparing the crystalline form II of sotagliflozin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A preparation method of afatinib Effective date of registration: 20211224 Granted publication date: 20200828 Pledgee: Industrial and Commercial Bank of China Limited Feixian sub branch Pledgor: SHANDONG NEW TIME PHARMACEUTICAL Co.,Ltd. Registration number: Y2021980016193 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20221028 Granted publication date: 20200828 Pledgee: Industrial and Commercial Bank of China Limited Feixian sub branch Pledgor: SHANDONG NEW TIME PHARMACEUTICAL Co.,Ltd. Registration number: Y2021980016193 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A preparation method of alfatinib Effective date of registration: 20221103 Granted publication date: 20200828 Pledgee: Industrial and Commercial Bank of China Limited Feixian sub branch Pledgor: SHANDONG NEW TIME PHARMACEUTICAL Co.,Ltd. Registration number: Y2022980020531 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |